Works matching IS 13419625 AND DT 2023 AND VI 28 AND IP 11
Results: 15
Correction to: Circ_0000419 acts as a tumor suppressor in gastric cancer development via regulating miR‑300/RGMB axis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Advantages and limitations of estrogen replacement therapy on hypogonadal survivors of childhood cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1563, doi. 10.1007/s10147-023-02405-y
- By:
- Publication type:
- Article
Superior detection of significant prostate cancer by transperineal prostate biopsy using MRI-transrectal ultrasound fusion image guidance over cognitive registration.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1545, doi. 10.1007/s10147-023-02404-z
- By:
- Publication type:
- Article
Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1487, doi. 10.1007/s10147-023-02403-0
- By:
- Publication type:
- Article
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1501, doi. 10.1007/s10147-023-02402-1
- By:
- Publication type:
- Article
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1538, doi. 10.1007/s10147-023-02401-2
- By:
- Publication type:
- Article
The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1461, doi. 10.1007/s10147-023-02400-3
- By:
- Publication type:
- Article
Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1520, doi. 10.1007/s10147-023-02399-7
- By:
- Publication type:
- Article
Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1554, doi. 10.1007/s10147-023-02398-8
- By:
- Publication type:
- Article
Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1511, doi. 10.1007/s10147-023-02396-w
- By:
- Publication type:
- Article
Oncology drug lag in Japan: has it improved over the last decade?
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1451, doi. 10.1007/s10147-023-02395-x
- By:
- Publication type:
- Article
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1530, doi. 10.1007/s10147-023-02394-y
- By:
- Publication type:
- Article
Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectives.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1431, doi. 10.1007/s10147-023-02388-w
- By:
- Publication type:
- Article
Immune checkpoint inhibitor therapy in neoadjuvant and adjuvant treatment for cancer: A paradigm shift in the treatment of resectable gastrointestinal cancer 3)A paradigm shift in the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1442, doi. 10.1007/s10147-023-02387-x
- By:
- Publication type:
- Article
Circ_0000419 acts as a tumor suppressor in gastric cancer development via regulating miR-300/RGMB axis.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1475, doi. 10.1007/s10147-023-02379-x
- By:
- Publication type:
- Article